Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

GSK names drug hunter challenge winners

Competition finds promising projects in anti-infectives, cancer and neurodegenerative diseases

- PMLiVE

GSK’s oncology president joins NuCana board

Paolo Paoletti also has experience in cancer research at Lilly

- PMLiVE

Building a business that is lean and specialised

Tuomo Pätsi on Celgene’s approach to access, marketing and the importance of culture

- PMLiVE

Merck: You need to win locally in consumer health

And company says it would consider targeted 'bolt-on' acquisitions

- PMLiVE

Succinct and ecancer team up on oncology education events

Will work together to support HCPs

- PMLiVE

Italy investigates Novartis vaccine after death toll reaches 13

Firms insist on the Fluad's safety, with 65 million doses given in the last 17 years

- PMLiVE

AIDS pandemic now at ‘the beginning of the end’

ONE Campaign says drug access is making the difference, but there's still more to do

- PMLiVE

AZ and Lilly start BACE inhibitor trial in Alzheimer’s

Early trials show promise for the BACE inhibitor AZD3293

- PMLiVE

Novartis’ Gilenya fails in difficult-to-treat form of MS

Drug no better than placebo as a treatment for primary progressive multiple sclerosis

- PMLiVE

Two new hires at Couch

And agency moves to Manchester

- PMLiVE

The challenge of poor adherence in type 2 diabetes

How can pharma help address this growing problem?

- PMLiVE

AZ and Cancer Research UK to collaborate on new medicines

Charity’s scientists to be given access to pharma company’s molecule library

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links